Kerafast adds new Zika virus antibody to its catalog of novel life science reagents
Company aims to help accelerate progress toward a vaccine or treatment for this global health threat Boston, MA.,(May 3, 2016)— Kerafast Inc., developers of an online platform that facilitates accessibility to unique bioresearch materials from laboratories across the globe, today announced the availability of a Zika virus antibody from Vanderbilt University. While researchers scramble to